Equities

BPH Global Ltd

BPH Global Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.002
  • Today's Change0.00 / 0.00%
  • Shares traded130.31k
  • 1 Year change-84.00%
  • Beta1.7264
Data delayed at least 20 minutes, as of Sep 16 2024 05:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year BPH Global Ltd grew revenues 32,244.12% from 340.00 to 109.97k while net income improved from a loss of 4.83m to a smaller loss of 2.27m.
Gross margin16.61%
Net profit margin-1,616.43%
Operating margin-1,616.42%
Return on assets-164.32%
Return on equity--
Return on investment--
More ▼

Cash flow in AUDView more

In 2024, cash reserves at BPH Global Ltd fell by 376.60k. Cash Flow from Financing totalled 697.04k or 633.85% of revenues. In addition the company used 1.26m for operations while cash from investing totalled 185.33k.
Cash flow per share-0.0026
Price/Cash flow per share--
Book value per share-0.0122
Tangible book value per share-0.0171
More ▼

Balance sheet in AUDView more

BPH Global Ltd uses little or no debt in its capital structure.
Current ratio0.2145
Quick ratio0.1796
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.